Jim Mullen | Xconomy

by in

Entry	Blogger	Date ▴	Location
Biogen Idec Moving to Weston?	Rebecca Zacks	10/03/08	Boston
Icahn Turns Up Heat, Files Suit to Force Biogen Idec to Turn Over Records of Failed Sale	Robert Buderi	04/09/08	Boston
Fearing Icahn’s Impact on Morale, Biogen Idec Launches Key Employee Retention Plan	Robert Buderi	02/15/08	Boston
An Analysis of Icahn’s Biogen Idec Strategy: Why Three Board Seats When Four Will Be Open?	Robert Buderi	01/31/08	Boston
MIT Teams With Italian Energy Giant, Elixir Postpones Its IPO, Biogen Idec Will Buy or Be Bought, & More	Rebecca Zacks	01/23/08	Boston
Perceived Risk, Culture Clash Did in Biogen Idec Sale, CEO Asserts	Henry Johnson	01/11/08	Boston
Biogen Idec-Icahn Story Likely Far From Over; History Says the Activist Investor Will Act Again	Robert Buderi	12/18/07	Boston
Biogen Inks $380 Million Deal With Swiss Company	Rebecca Zacks	11/20/07	Boston
Biogen-Icahn? Pfiz-ogen or Pfiz-zyme? Is All of Cambridge Biotech Suddenly Up For Sale?	Robert Buderi	10/24/07	Boston
Icahn Offered $23 Billion for Biogen Idec—Elan Won’t Block Sale	Robert Buderi	10/15/07	Boston
Biogen Idec Shares Enjoy Nice Pop; Forget Rumors of Being Acquired, Company Hasn’t Given Up on a Major Acquisition of Its Own	Robert Buderi	09/07/07	Boston
Bullish Biogen Idec CEO Forecasts 15 Percent Revenue Growth While Fending Off Talk of Icahn Plans	Robert Buderi	09/06/07	Boston
Keeping Biogen Idec Innovative: Jim Mullen Interview (Part 2)	Robert Buderi	08/17/07	Boston
Page 1 of 1

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.